Advantages and common side effects of tucatinib/tucatinib

Tucatinib is a highly selective HER2 tyrosine kinase inhibitor. Its most significant advantage is that it can precisely target the HER2 signaling pathway while avoiding significant inhibition of EGFR. This molecular selectivity not only improves its anti-tumor efficacy, but also significantly reduces the skin toxicity and gastrointestinal side effects caused by common targeted drugs.

Tucatinib is approved by the FDA for the treatment of HER2-positive metastatic breast cancer. It is especially suitable for patients with brain metastases or those who have progressed after standard treatment. Its combination therapy usually includes trastuzumab and capecitabine. Compared with traditional HER2-targeted drugs, tucatinib has unique advantages in controlling central nervous system metastases. Thanks to its ability to cross the blood-brain barrier, tucatinib has been proven in clinical studies to prolong the progression-free survival of patients with central nervous system metastases.

In addition to the breakthrough in efficacy, tucatinib is also well tolerated. Due to its weak inhibition of EGFR, the probability of patients experiencing severe rash or severe diarrhea is significantly reduced. Its oral administration method also facilitates long-term use and home management, helping to improve patient compliance. In clinical use, most patients are able to maintain standard doses without frequent adjustments. However, this does not mean that tucatinib has no side effects. Common drug-related adverse reactions mainly include mild to moderate diarrhea, fatigue, nausea, hand-foot syndrome, and elevated transaminases. Some patients may also develop abnormal liver function during treatment, and liver enzyme levels need to be evaluated regularly under physician supervision.

In addition, although the side effects of tucatinib are generally controllable, the incidence of adverse reactions may increase when used in combination with chemotherapy drugs. Therefore, in clinical practice, doctors usually make individualized dose adjustments based on the patient's underlying condition and treatment tolerance.

Reference materials:https://www.tukysa.com/